Browsing "Pathology" by Author Zannettino, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
PreviewIssue DateTitleAuthor(s)
2005Elevated serum levels of stromal-derived factor-1α are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patientsZannettino, A.; Farrugia, A.; Kortesidis, A.; Manavis, J.; To, L.; Martin, S.; Diamond, P.; Tamamura, H.; Lapidot, T.; Fujii, N.; Gronthos, S.
2014EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specificationHemming, S.; Cakouros, D.; Isenmann, S.; Cooper, L.; Menicanin, D.; Zannettino, A.; Gronthos, S.
2006Imatinib as a potential antiresorptive therapy for bone diseaseDewar, A.; Farrugia, A.; Condina, M.; To, L.; Hughes, T.; Vernon-Roberts, B.; Zannettino, A.
2012Immunoselected STRO-3⁺ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs: Laboratory investigationGhosh, P.; Moore, R.; Vernon-Roberts, B.; Goldschlager, T.; Pascoe, D.; Zannettino, A.; Gronthos, S.; Itescu, S.
2008Long-term imatinib therapy promotes bone formation in CML patientsFitter, S.; Dewar, A.; Kostakis, P.; To, L.; Hughes, T.; Roberts, M.; Lynch, K.; Vernon-Roberts, B.; Zannettino, A.
2012The immunoreceptor tyrosine-based activation motif (ITAM)-related factors are increased in synovial tissue and vasculature of rheumatoid arthritic jointsCrotti, T.; Dharmapatni, A.; Alias, E.; Zannettino, A.; Smith, M.; Haynes, D.
2012Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?Noll, J.; Williams, S.; Purton, L.; Zannettino, A.